文献速递眼底病与葡萄膜炎

视网膜血管增生性肿瘤相关眼内并发症的玻璃体切除术手术结局

SURGICAL OUTCOMES OF PARS PLANA VITRECTOMY FOR INTRAOCULAR COMPLICATIONS RELATED TO VASOPROLIFERATIVE TUMOR OF THE RETINA.
PubMed 文献 · Retina · 2023-01-01

回顾性研究纳入2005至2020年在谢菲尔德教学医院NHS信托接受玻璃体切除术的17例视网膜血管增生性肿瘤患者,评估手术安全性和有效性。术后14/17(82.4%)视力稳定,3/17(17.6%)恶化;视网膜前膜和玻璃体出血亚组结局良好。肿瘤厚度≥2 mm者视觉结局较<2 mm者差(P < 0.05)。

要点

  • 玻璃体切除术治疗视网膜血管增生性肿瘤相关眼内并发症安全有效,并发症率低。
  • 视网膜前膜和玻璃体出血患者术后结局良好。
  • 肿瘤厚度≥2 mm者视觉结局较<2 mm者差(P < 0.05)。

核心结论

  • 玻璃体切除术是处理视网膜血管增生性肿瘤相关眼内并发症的有效且安全的方法,结局良好且并发症率低,尤其适用于视网膜前膜和玻璃体出血患者。
  • 本研究是评估视网膜血管增生性肿瘤并发症玻璃体切除术结局的最大数据集之一。

研究设计与样本

  • 回顾性研究,纳入2005至2020年在谢菲尔德教学医院NHS信托接受玻璃体切除术的17例视网膜血管增生性肿瘤患者。
  • 收集并评估患者人口学资料、临床特征、术中数据和手术结局。

主要发现

  • 平均年龄52岁。
  • 玻璃体切除术指征包括视网膜前膜(n = 7)、玻璃体出血(n = 5)、视网膜脱离(n = 3)、诊断性(n = 1)和其他(n = 1)。
  • 玻璃体切除术后,14/17(82.4%)视力稳定,3/17(17.6%)恶化。
  • 视网膜前膜剥离亚组结局良好,6/7(85.7%)症状改善或稳定,平均最小分辨角对数视力从0.719 [6/30] ± 0.267 [6/12]改善至0.476 [6/19] ± 0.271 [6/12]。
  • 玻璃体出血手术患者结局良好,3/5(60%)出血消退且无复发,5/5(100%)经一次或多次手术后出血消退。

关键数值与推荐

  • 视网膜脱离手术结局:术前最小分辨角对数视力2.126 [HM] ± 0.301 [6/12],术后1.185 [6/95] ± 0.522 [6/19],1例视网膜脱离复发。
  • 视网膜前膜组中3例术中接受视网膜血管增生性肿瘤辅助治疗,4例未接受,两组结局或并发症无差异。
  • 肿瘤厚度≥2 mm者视觉结局较<2 mm者差(P < 0.05)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To investigate the safety and efficacy of vitrectomy pars plana vitrectomy in managing intraocular complications relating to vasoproliferative tumors of the retina (VPL). METHODS: Retrospective study. 17 patients with VPL who underwent vitrectomy at Sheffield Teaching Hospital NHS Trust from 2005 to 2020 were included. Patient demographics, clinical characteristics, intraoperative data, and surgical outcomes were collected and evaluated. RESULTS: The mean age was 52 years. Indications for pars plana vitrectomy included epiretinal membrane (n = 7), vitreous hemorrhage (n = 5), retinal detachment (n = 3), diagnostic (n = 1), and others (n = 1). After pars plana vitrectomy, 14/17 (82.4%) have stabilized vision and 3/17 (17.6%) deteriorated. Subgroup analysis of epiretinal membrane peel had good outcomes with 6/7 (85.7%) noticing improvement or stabilization of symptoms and mean logarithm of minimal angle of resolution visual acuity improved from 0.719 [6/30] ± 0.267 [6/12] to 0.476 [6/19] ± 0.271 [6/12]. Patients undergoing surgery for vitreous hemorrhage also had good outcomes with resolution (and no recurrence) of the hemorrhage in 3/5 (60%) and 5/5 (100%) with one or more surgeries, respectively. Outcomes for retinal detachment surgery were logarithm of minimal angle of resolution 2.126 [HM] ± 0.301 [6/12] preoperatively and 1.185 [6/95] ± 0.522 [6/19] postoperatively, with one recurrence of retinal detachment. In the epiretinal membrane group, three patients had adjunctive treatment for VPL intraoperatively and four patients had none, and no difference found between the two groups in outcome or complications. Tumor with thickness of ≥2 mm exhibited inferior visual outcomes compared with <2 mm ( P < 0.05). CONCLUSION: This is one of the largest data sets in looking at outcomes of vitrectomy for complications of VPL. Pars plana vitrectomy is effective and safe in managing VPL-related intraocular complications with good outcomes and a low rate of complications, especially for patients with epiretinal membrane and vitreous hemorrhage.

来源:Retina,查看原文。版权归原作者所有。

引用

  1. Jong JLZ, Jawaheer L, Spiteri-Cornish K, et al. SURGICAL OUTCOMES OF PARS PLANA VITRECTOMY FOR INTRAOCULAR COMPLICATIONS RELATED TO VASOPROLIFERATIVE TUMOR OF THE RETINA. Retina. 2023. PMID: 37418640. doi:10.1097/IAE.0000000000003886

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。